Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: RTOG 1306 Principal Investigator: Govindan, Ramaswamy
Title: A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to determine whether adding treatment with either erlotinib or crizotinib prior to standard treatment with chemotehrapy and radiation helps to better control lung cancer in patients who have tumors with specific changes that make them sensitive to these drug.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)